Assessing oxytocin's effect on bleeding during second trimester procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of prophylactic oxytocin in reducing hemorrhage rates during dilation and evacuation (D&E) procedures performed in a clinical setting for patients at 18 weeks gestational age and above. Participants will receive either oxytocin combined with normal saline or normal saline alone. The goal is to determine if the use of oxytocin can lead to better outcomes in terms of bleeding control during these procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* clinic-based D\&E at 18 weeks gestational age and above
* speaks English or Spanish

Exclusion Criteria:

* refuses IV
* history of coagulopathy
* anticoagulant use in the preceding five days
* chorioamnionitis or sepsis
* suspected placenta accreta spectrum
* intrauterine fetal demise
* multiple gestation
* use of misoprostol for cervical preparation

Where it's running

• Comprehensive Women's Health Center
  Denver, Colorado, United States Recruiting

Study contacts

• Study coordinator: Megan Masten, MD
• Email: megan.masten@cuanschutz.edu
• Phone: 303-724-8576

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Simplified Tranexamic Acid Regimen for Trauma with Hemorrhage

  This trial tests a simplified TXA dosing approach to see if it safely helps adults with major trauma and significant bleeding.

  Recruiting at 3 sites Phase 4 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 2 other locations · NCT07869537

• Bleeding control after single-ray amputation: Hemocoll vs Avitene vs bone wax

  This trial tests whether Hemocoll, Avitene, or bone wax better stop bleeding from exposed bone after a planned single-ray amputation in adults.

  Recruiting at 3 sites Adichunchanagiri Institute of Medical Sciences, B G Nagara · Kolār, Karnataka and 2 other locations · NCT07788846

• Tailored lower‑intensity blood thinner plan after left atrial appendage closure to prevent stroke

  This project tests whether people with non‑valvular atrial fibrillation who get a left atrial appendage closure can stop blood thinners after taking low‑dose apixaban (2.5 mg twice daily) for 3 months, compared with people who stay on standard‑dose DOACs.

  Recruiting National Medical Research Center for Therapy and Preventive Medicine · Moscow · NCT07575867

• Catheter ablation plus LAAC vs anticoagulation in frail elderly A-fib patients

  This study tests whether adding left atrial appendage closure to ablation is as good as using long-term blood thinners in frail people aged 75 and up with atrial fibrillation.

  Recruiting Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT07441382

• Preventing pneumonia after brain hemorrhage with extra mouth care and preventive antibiotics

  This will test whether enhanced oral hygiene combined with preventive antibiotics can help adults who recently had a spontaneous intracerebral hemorrhage avoid pneumonia.

  Recruiting Phase 4 Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07311343

• Comparing tranexamic acid dosing during heart surgery with cardiopulmonary bypass

  This research will test whether three different tranexamic acid dosing schedules keep fibrinolysis suppressed longer and limit bleeding in adults having elective heart surgery with cardiopulmonary bypass.

  Recruiting University of Ioannina · Ioannina · NCT07164300

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.